The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
David Marlin is the President and Co-Founder of MetaComet® Systems, a prominent provider of royalty automation tools. Since founding the company in 2000, David has spearheaded the development of a suite of best-in-class systems that effectively facilitate royalty processes for nearly 200 publishers. David has also served as the chair for The Book Industry Study Group’s Rights Committee and Digital Sales Committee.
Before establishing MetaComet Systems, David served as a technology consultant for renowned publishers, collaborating with notable companies such as Random House, Penguin, HarperCollins, Holtzbrinck, Macmillan, Scholastic, Time Warner, and many others. David holds both an MBA and a BA from Columbia University in New York.
If you’re involved in licensing technology from a university, research institution, or federal lab—or granting those rights to others—managing royalties is one of the most critical (and complex) parts of the process.
Not all software is created equal. For the large majority of royalty-based businesses, specialist solutions will beat generalist products on every count. Here are just ten reasons why.
Learn what royalty rates are, how they’re calculated, what affects them, and what to expect in a licensing agreement in this practical guide.
Revenue sharing gives licensees a cut of revenue based on use or sales, aligning payouts with performance and encouraging long-term success.
Let’s break down what an intellectual property license is, explore different types of IP licenses, explain what goes into an IP licensing agreement, and walk through royalty rates and licensing fees. We’ll also share best practices to help manage intellectual property licensing deals with clarity and confidence.
Royalty agreements are sometimes regarded as the domain of legal professionals, and there’s no doubt they can be complicated. But everyone involved in the creation and sale of IP should understand the basics.
Here’s our guide to how author royalties work, what licensees can do to manage them efficiently, and how MetaComet can help.
Royalties are at the core of invention and innovation in biotech. But establishing agreements, calculating rates, and handling payments can be complex, and processes don’t always get the investment they deserve.
At MetaComet, we work with financial professionals across a wide range of industries to make royalty processes smoother, more accurate, and more efficient. In this guide, we’ll answer some of the most frequently asked questions from licensees and publishers about how royalties are paid.
For finance professionals working in biotech, understanding how patent royalties work is essential for managing budgets, structuring agreements, ensuring compliance, and supporting strategic business decisions.
"*" indicates required fields